Steve Platts
NASA chief scientist who controls crew radiation data release for Artemis missions.
Last refreshed: 11 April 2026 · Appears in 1 active topic
Why did NASA defer Artemis II radiation data rather than releasing it at splashdown?
Timeline for Steve Platts
Third radiation window closes with no data
Artemis II Moon MissionDose data dark 72 hours on
Artemis II Moon MissionNASA defers radiation dose to peer review
Artemis II Moon Mission10:30 PM press conference is radiation data's first fork
Artemis II Moon MissionNASA's post-mission press conference disclosed no data
Artemis II Moon Mission- What is the Artemis II crew radiation dose?
- NASA has deferred the figure to a post-mission research solicitation. No dose was disclosed at the post-splashdown press conference.Source: DB event nasa-defers-radiation-dose-to-peer-review
- Who is Steve Platts at NASA?
- Steve Platts is NASA Chief Scientist for Human Research, responsible for crew radiation risk assessment and data disclosure protocols.Source: DB entity background
- Why was radiation data not released after Artemis II splashdown?
- NASA routed the data through a formal research solicitation rather than an operational safety release, consistent with pre-launch statements from the Human Research Programme chief scientist.Source: DB events 2219 2214
Background
Steve Platts leads human research risk assessment at NASA and holds authority over how crew radiation dose data from Artemis missions is disclosed. He was absent from the post-splashdown press conference at 22:30 EDT on 10 April, the event where radiation figures were most widely expected. NASA subsequently confirmed it has deferred dose data to a post-mission research solicitation, not an operational safety release.
Platts serves as Chief Scientist for NASA Human Research Programme, based at Johnson Space Centre. He told the Planetary Society before Artemis II that radiation findings would be published through a formal research process, framing the data as a scientific output rather than a safety disclosure. His team monitors career radiation limits, cancer risk projections, and in-mission dosimetry for NASA astronauts.
The deferred radiation disclosure is significant beyond Artemis II. NASA Space Policy Directive-1 requires a crewed Mars mission, which carries FAR greater radiation exposure than a lunar flyby. If the agency cannot publicly disclose a ten-day dose in a timely way, the precedent for Mars mission transparency is troubling. Platts programme will set those standards.
